TYK Medicines sues Huiyu Pharma over disputed TY-9591 cooperation dealPUBT·Jul 22 at 09:52 AM02410-4.08%688553+4.60%
Midday Market Review on April 9: SSE Index Drops 0.73% in Half-Day, Computing Power Hardware Stocks Strengthen Against the TrendWallstreetcn·Apr 8 at 10:30 PM000001+0.72%301201+2.44%
HUIYU PHARMACEUTICAL: Plans to collaborate with professional institutions to establish a private equity fund, primarily investing in the biomedical field36Kr·Nov 27, 2025 at 03:11 AM688553+4.60%
HUIYU PHARMACEUTICAL: The company participates in the national centralized drug procurement and intends to be selectedZhitong·Oct 28, 2025 at 05:32 AM688553+4.60%
HUIYU PHARMACEUTICAL: Shareholder Huang Qianyi's shares in the company have been judicially frozen and pending frozenZhitong·Oct 10, 2025 at 03:38 AM688553+4.60%
HUIYU PHARMACEUTICAL: Injectable Paclitaxel (Albumin-Bound) Obtains Overseas Listing LicenseZhitong·Oct 9, 2025 at 03:19 AM688553+4.60%
HUIYU PHARMACEUTICAL shareholder Wang Xiaopeng plans to reduce his holdings by no more than 3%Zhitong·Sep 24, 2025 at 06:17 AM688553+4.60%
The chemical pharmaceutical sector rose in early trading, with SUNFLOWER hitting the daily limit of a 20cm increaseZhitong·Sep 21, 2025 at 08:36 PM688553+4.60%300705+1.01%
HUIYU PHARMACEUTICAL and its subsidiaries have obtained overseas listing licenses for multiple productsZhitong·Sep 15, 2025 at 05:02 AM688553+4.60%
HUIYU PHARMACEUTICAL: Shanghai Shuangsa reduced holdings by 0% in MarchZhitong·Aug 29, 2025 at 06:19 AM688553+4.60%
HUIYU PHARMACEUTICAL: Injectable Parecoxib Sodium and Injectable Pemetrexed Disodium have obtained overseas listing approvalZhitong·Aug 13, 2025 at 02:56 AM688553+4.60%
HUIYU PHARMACEUTICAL: The first subject in the clinical trial of injectable HY05350I has been dosedZhitong·Aug 4, 2025 at 03:31 AM688553+4.60%
HUIYU PHARMACEUTICAL: The first subject of the Phase I clinical trial for injectable HY0001a has been dosedZhitong·Jul 30, 2025 at 03:46 AM688553+4.60%
